Global Bromhidrosis Disease Treatment Market by Treatment (Botox, Liposuction, Surgery), Indication (Erythrasma, Intertrigo, Trichomycosis Axillaries) - Forecast 2024-2030- Product Image

Sale

Global Bromhidrosis Disease Treatment Market by Treatment (Botox, Liposuction, Surgery), Indication (Erythrasma, Intertrigo, Trichomycosis Axillaries) - Forecast 2024-2030

Report
186 Pages
March 2024
Region: Global
360iResearch™
ID: 5716198

UP TO €846EUR$875USD£727GBP OFF until Dec 31^st 2024

The Bromhidrosis Disease Treatment Market size was estimated at USD 448.67 million in 2023, USD 489.03 million in 2024, and is expected to grow at a CAGR of 9.39% to reach USD 841.04 million by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Bromhidrosis Disease Treatment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Bromhidrosis Disease Treatment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Bromhidrosis Disease Treatment Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Biovencer Healthcare Pvt. Ltd., Boehringer Ingelheim International GmbH, Galderma S.A., Hikma Pharmaceuticals PLC, Ipsen Biopharmaceuticals, Inc., Johnson & Johnson, Journey Medical Corp., Medytox Inc., Merz Pharma GmbH and Co. KGaA, Novartis AG, and Pfizer Inc.

Market Segmentation & Coverage

This research report categorizes the Bromhidrosis Disease Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

Treatment
- Botox
- Liposuction
- Surgery
Indication
- Erythrasma
- Intertrigo
- Trichomycosis Axillaries
- Type 2 Diabetes

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

What is the market size and forecast of the Bromhidrosis Disease Treatment Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Bromhidrosis Disease Treatment Market?
What are the technology trends and regulatory frameworks in the Bromhidrosis Disease Treatment Market?
What is the market share of the leading vendors in the Bromhidrosis Disease Treatment Market?
Which modes and strategic moves are suitable for entering the Bromhidrosis Disease Treatment Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Bromhidrosis Disease Treatment Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing cases of bromhidrosis and kidney and liver diseases
5.1.1.2. Rising investments in the clinical trials and R&D activities
5.1.1.3. Awareness about body odor issues
5.1.2. Restraints
5.1.2.1. High cost of treatment
5.1.3. Opportunities
5.1.3.1. Rapid proliferation of regulatory approvals of treatment products
5.1.3.2. Adoption of microwave-based therapy for axillary hyperhidrosis and bromhidrosis
5.1.4. Challenges
5.1.4.1. Product recalls and adverse health effects
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Bromhidrosis Disease Treatment Market, by Treatment

6.1. Introduction
6.2. Botox
6.3. Liposuction
6.4. Surgery

7. Bromhidrosis Disease Treatment Market, by Indication

7.1. Introduction
7.2. Erythrasma
7.3. Intertrigo
7.4. Trichomycosis Axillaries
7.5. Type 2 Diabetes

8. Americas Bromhidrosis Disease Treatment Market

8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States

9. Asia-Pacific Bromhidrosis Disease Treatment Market

9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam

10. Europe, Middle East & Africa Bromhidrosis Disease Treatment Market

10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom

11. Competitive Landscape

11.1. FPNV Positioning Matrix
11.2. Market Share Analysis, By Key Player
11.3. Competitive Scenario Analysis, By Key Player

12. Competitive Portfolio

12.1. Key Company Profiles
12.1.1. AbbVie Inc.
12.1.2. Biovencer Healthcare Pvt. Ltd.
12.1.3. Boehringer Ingelheim International GmbH
12.1.4. Galderma S.A.
12.1.5. Hikma Pharmaceuticals PLC
12.1.6. Ipsen Biopharmaceuticals, Inc.
12.1.7. Johnson & Johnson
12.1.8. Journey Medical Corp.
12.1.9. Medytox Inc.
12.1.10. Merz Pharma GmbH and Co. KGaA
12.1.11. Novartis AG
12.1.12. Pfizer Inc.
12.2. Key Product Portfolio

13. Appendix

13.1. Discussion Guide
13.2. License & Pricing

List of Figures

FIGURE 1. BROMHIDROSIS DISEASE TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. BROMHIDROSIS DISEASE TREATMENT MARKET DYNAMICS
FIGURE 7. BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
FIGURE 8. BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 10. BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 12. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 14. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. ASIA-PACIFIC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. ASIA-PACIFIC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. BROMHIDROSIS DISEASE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 20. BROMHIDROSIS DISEASE TREATMENT MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. BROMHIDROSIS DISEASE TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 6. BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY BOTOX, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY LIPOSUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 10. BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ERYTHRASMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INTERTRIGO, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TRICHOMYCOSIS AXILLARIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TYPE 2 DIABETES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 16. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 17. ARGENTINA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 18. ARGENTINA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 19. BRAZIL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 20. BRAZIL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 21. CANADA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 22. CANADA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 23. MEXICO BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 24. MEXICO BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 28. ASIA-PACIFIC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 29. ASIA-PACIFIC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 30. ASIA-PACIFIC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 31. AUSTRALIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 32. AUSTRALIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 33. CHINA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 34. CHINA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 35. INDIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 36. INDIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 37. INDONESIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 38. INDONESIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 39. JAPAN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 40. JAPAN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 41. MALAYSIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 42. MALAYSIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 43. PHILIPPINES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 44. PHILIPPINES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 45. SINGAPORE BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 46. SINGAPORE BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 47. SOUTH KOREA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 48. SOUTH KOREA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 49. TAIWAN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 50. TAIWAN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 51. THAILAND BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 52. THAILAND BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 53. VIETNAM BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 54. VIETNAM BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 58. DENMARK BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 59. DENMARK BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 60. EGYPT BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 61. EGYPT BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 62. FINLAND BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 63. FINLAND BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 64. FRANCE BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 65. FRANCE BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 66. GERMANY BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 67. GERMANY BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 68. ISRAEL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 69. ISRAEL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 70. ITALY BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 71. ITALY BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 72. NETHERLANDS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 73. NETHERLANDS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 74. NIGERIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 75. NIGERIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 76. NORWAY BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 77. NORWAY BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 78. POLAND BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 79. POLAND BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 80. QATAR BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 81. QATAR BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 82. RUSSIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 83. RUSSIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 84. SAUDI ARABIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 85. SAUDI ARABIA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 86. SOUTH AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 87. SOUTH AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 88. SPAIN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 89. SPAIN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 90. SWEDEN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 91. SWEDEN BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 92. SWITZERLAND BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 93. SWITZERLAND BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 94. TURKEY BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 95. TURKEY BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 96. UNITED ARAB EMIRATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 97. UNITED ARAB EMIRATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 100. BROMHIDROSIS DISEASE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 101. BROMHIDROSIS DISEASE TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
TABLE 102. BROMHIDROSIS DISEASE TREATMENT MARKET LICENSE & PRICING

Companies Mentioned

AbbVie Inc.
Biovencer Healthcare Pvt. Ltd.
Boehringer Ingelheim International GmbH
Galderma S.A.
Hikma Pharmaceuticals PLC
Ipsen Biopharmaceuticals, Inc.
Johnson & Johnson
Journey Medical Corp.
Medytox Inc.
Merz Pharma GmbH and Co. KGaA
Novartis AG
Pfizer Inc.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	186
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 489.03 Million
Forecasted Market Value ( USD ) by 2030	$ 841.04 Million
Compound Annual Growth Rate	9.3%
Regions Covered	Global
No. of Companies Mentioned	12

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3262EUR$3,374USD£2,804GBP €3624EUR$3,749USD£3,115GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4132EUR$4,274USD£3,551GBP €4591EUR$4,749USD£3,946GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5002EUR$5,174USD£4,299GBP €5558EUR$5,749USD£4,777GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5872EUR$6,074USD£5,047GBP €6524EUR$6,749USD£5,608GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7612EUR$7,874USD£6,543GBP €8458EUR$8,749USD£7,270GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects

The report addresses key questions such as

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Global Krabbe Disease Treatment Market by Disease Type (Infantile, Late-onset), Treatment (Anticonvulsant Agents, Bone Marrow Transplantation, Muscle Relaxer Drugs), Distribution Channel - Forecast 2024-2030

Global Thyroid Eye Disease Treatments Market by Drug (Corticosteroid, Monoclonal Antibody, Vitamin), Route of Administration (Oral, Topical), Treatment, Diagnosis, Distribution - Forecast 2024-2030

Rare Endocrine Disease Treatment - Global Strategic Business Report

Global Gaucher Disease Drugs Market Size, Share & Trends Analysis Report by Type (Type 1, Type 2, Type 3, Others) By Therapy (Enzyme Replacement Therapy, Substrate Replacement Therapy, Others), Region, and Segment Forecasts, 2023-2030

Global Acromegaly Treatment Market Size, Share & Trends Analysis Report by Drug Type (Somatostatin Analogs, GHRA), End-use (Hospitals & Clinics), Region, and Segment Forecasts, 2023-2030

About the Bromhidrosis Disease Drug Market